TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo
US11440960B2 · kind B2 · utility
0Cited by
30References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2018 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Jan 13, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies specific for one or more antigens, bispecific antibodies containing one or more domains with specificity to the target(s), and to immunocytokines. The present invention also provides methods of treatment, uses and pharmaceutical compositions comprising the antibodies, bispecific antibodies and immunocytokines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.